• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Myriad Genetics Inc. (MYGN)

    -NasdaqGS
    37.42 Down 0.92(2.40%) Jan 30, 4:00PM EST
    |After Hours : 37.42 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:38.34
    Open:38.27
    Bid:N/A
    Ask:47.50 x 500
    1y Target Est:38.92
    Beta:0.53
    Next Earnings Date: 3-Feb-15MYGN Earnings announcement
    Day's Range:37.36 - 38.61
    52wk Range:27.02 - 42.50
    Volume:1,075,045
    Avg Vol (3m):850,592
    Market Cap:2.73B
    P/E (ttm):21.08
    EPS (ttm):1.78
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MYGN

    Comparison

    Symbol% ChgMkt Cap
    MYGNDown 2.40%2.73B
    ABTDown 1.10%67.40B

    Key Statistics

    Forward P/E (1 yr):16.71
    P/S (ttm):3.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :1.85
    Quarterly EPS Est (Dec-14) :0.35
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):1.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback